Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Comparing cisplatin and carboplatin, which factor primarily accounts for the difference in nephrotoxicity between these two chemotherapeutic agents?

Different rates of renal clearance. ***Different rates of renal clearance*** - **Cisplatin** is largely cleared by **glomerular filtration** and **tubular secretion**, leading to higher concentrations in the renal tubules and increased nephrotoxicity. - **Carboplatin** is primarily cleared by **glomerular filtration** without significant tubular secretion, resulting in lower renal exposure and reduced nephrotoxicity. *Variability in DNA adduct formation* - While both drugs form DNA adducts to exert their therapeutic effect, the specific differences in adduct formation do not primarily explain their differential nephrotoxicity. - The mechanism of nephrotoxicity is more related to the drugs' delivery and concentration in renal cells rather than the inherent nature of their DNA-damaging activity. *Difference in protein binding* - Both cisplatin and carboplatin bind to plasma proteins, but this factor alone does not account for the significant difference in their nephrotoxic profiles. - Protein binding can influence drug distribution and elimination, but the **intrinsic renal handling** mechanisms are more critical for specific organ toxicity. *Dose-dependent cellular uptake* - Both drugs exhibit dose-dependent cellular uptake in target cancer cells, which is crucial for efficacy. - However, the **differential nephrotoxicity** is more closely tied to their **pharmacokinetics** within the kidney itself (e.g., clearance rates) rather than just general cellular uptake.

Q: In a drug exhibiting first-order kinetics, how would an increase in dose affect the time required to reach the steady-state concentration?

It would not change. ***It would not change*** - For drugs following **first-order kinetics**, the time required to reach steady-state concentration is determined solely by the **half-life (t½)** of the drug, which is independent of the dose. - Steady-state is generally achieved after approximately **4 to 5 half-lives**, regardless of the administered dose size, provided the dosing interval remains constant. *It would decrease* - An increase in dose does not shorten the time to reach steady state for a first-order drug, as the **elimination rate** is proportional to the plasma concentration. - The drug still needs to undergo the same number of half-lives to accumulate to a steady level. *It would increase* - Increasing the dose does not prolong the time to reach steady state for a drug exhibiting first-order kinetics. - The **kinetics of elimination** remain proportional to the amount of drug in the body, meaning a larger dose will be eliminated proportionally faster, maintaining the same half-life. *It would double* - The time to reach steady state is a function of the drug's elimination half-life, not the magnitude of the dose. - Doubling the dose will **double the steady-state concentration**, but not the time it takes to achieve that concentration.

Q: The graph below shows dose-response curves for three drugs A, B, and C. Which of the following drugs has the highest potency?

Drug A. ***Drug A*** - Potency is inversely related to the **concentration required to produce an effect (EC50)**. A lower EC50 indicates higher potency. - Drug A achieves its half-maximal effect (indicated by the dashed line) at approximately **0.01 concentration**, which is the lowest among all three drugs. *Drug B* - Drug B reaches its half-maximal effect at a concentration of approximately **1**, which is significantly higher than Drug A. - This indicates that a larger dose of Drug B is needed to achieve the same effect as Drug A, making it less potent than A. *Drug C* - Drug C requires the highest concentration, approximately **100**, to achieve its half-maximal effect. - This signifies that Drug C is the least potent among the three drugs, as it demands a much larger dose for an equivalent effect compared to A and B. *Both Drug A & B* - While Drug A is highly potent, Drug B is less potent as it requires a higher concentration to elicit its effect. - Therefore, it is incorrect to state that both drugs A and B have the highest potency.

Q: Which of the following statements is false regarding intracellular receptors?

They are the fastest acting receptors.. ***They are the fastest acting receptors.*** - Intracellular receptors regulate gene expression and protein synthesis, which is a **slow process** taking hours or days to manifest effects. - Receptors like **ligand-gated ion channels** are the fastest acting, producing effects within milliseconds due to direct ion flow. *Act by regulating gene expression* - Intracellular receptors, such as **steroid hormone receptors**, typically bind to their ligands within the cytoplasm or nucleus. - This binding leads to their translocation to the nucleus (if not already there), where they act as **transcription factors** to regulate gene expression. *Glucocorticoid receptors are a type of intracellular receptor.* - **Glucocorticoids** are **lipid-soluble hormones** that can readily cross the cell membrane. - They bind to specific intracellular receptors in the cytoplasm, forming a hormone-receptor complex that then translocates to the nucleus. *DNA contains hormone responsive elements.* - Once the activated intracellular hormone-receptor complex enters the nucleus, it binds to specific sequences on the DNA called **hormone responsive elements (HREs)**. - This binding initiates or represses the transcription of target genes, leading to changes in **protein synthesis**.

Q: What is the role of oxidation in biotransformation?

Functionalization reaction. ***Functionalization reaction*** - Oxidation is a **Phase I biotransformation reaction**, which primarily involves introducing or exposing a functional group (like hydroxyl, carboxyl, amine) on the parent compound. - This makes the molecule more **polar** and often more reactive, preparing it for subsequent Phase II (conjugation) reactions. *Conjugation reaction* - Conjugation reactions are **Phase II biotransformation reactions**, which involve the covalent attachment of a large, highly polar, endogenous molecule (e.g., glucuronic acid, sulfate, glutathione) to the functional group created during Phase I. - Their main role is to further increase **water solubility** and facilitate **excretion**, rather than introducing functional groups. *Synthetic reaction* - The term "synthetic reaction" is a general chemical term and not a specific, commonly used classification for biotransformation phases in pharmacology. - While biotransformation involves chemical synthesis within the body, this term does not accurately describe the specific role of oxidation in drug metabolism. *Felson reaction* - The "Felson reaction" is **not a recognized term** in the context of biotransformation or drug metabolism. - This option is a distracter and does not correspond to any known biochemical process.

Q: Which of the following is the longest acting oral anticoagulant?

Bishydroxycoumarin. ***Bishydroxycoumarin*** - **Bishydroxycoumarin** (dicoumarol) has a very long duration of action, with effects lasting up to 2-10 days after a single dose due to its slow metabolism and excretion. - Its prolonged action and unpredictable anticoagulant response have led to it being largely replaced by other oral anticoagulants like **warfarin** in clinical practice. *Warfarin* - **Warfarin** has a half-life of approximately 36-42 hours, leading to an anticoagulant effect that lasts for about 2-5 days after discontinuation. - It is a widely used oral anticoagulant, but its duration of action is significantly shorter than that of bishydroxycoumarin. *Acenocoumarol* - **Acenocoumarol** has a relatively short half-life of about 8-11 hours, and its anticoagulant effects typically dissipate within 1-2 days after discontinuation. - It is often preferred in situations where a rapid reversal of anticoagulation might be necessary, due to its shorter duration of action compared to warfarin. *Phenindione* - **Phenindione** is an indandione derivative, a class of oral anticoagulants, with a duration of action of approximately 2-4 days. - It is rarely used now due to a higher incidence of adverse effects, including hypersensitivity reactions and hematological toxicities, compared to coumarin derivatives.

Q: Glucuronidation takes place in?

Liver. ***Liver*** - The **liver** is the primary organ responsible for **glucuronidation**, a crucial phase II detoxification pathway [1]. - This process conjugates **glucuronic acid** with various endogenous and exogenous substances, making them more water-soluble for excretion [1]. *RBC* - **Red blood cells (RBCs)** primarily function in **oxygen transport** and lack the extensive metabolic machinery for glucuronidation. - While they possess some enzymatic activities, detoxification pathways like glucuronidation are not a significant function. *Pancreas* - The **pancreas** is mainly involved in producing **digestive enzymes** and **hormones** (insulin, glucagon) for blood glucose regulation. - It does not play a direct role in drug or toxin metabolism through processes like glucuronidation. *Thyroid* - The **thyroid gland** is responsible for producing **thyroid hormones** that regulate metabolism. - Its metabolic activity is distinct from the detoxification functions performed by the liver, and it does not perform glucuronidation.

Q: Most common enzyme for drug metabolism and detoxification reactions?

CYP3A4. ***CYP3A4*** - **CYP3A4** is the most abundant and versatile **cytochrome P450 enzyme** in the human liver and intestine, responsible for metabolizing approximately **50% of all clinically used drugs**. - Its broad substrate specificity and high expression levels make it a critical player in **drug detoxification** and metabolism. *CYP1A2* - While important, **CYP1A2** is primarily involved in the metabolism of only about **10% of therapeutic drugs** and specific endogenous compounds. - It plays a significant role in the metabolism of **caffeine** and some **polycyclic aromatic hydrocarbons**, but its overall contribution to drug metabolism is less than that of CYP3A4. *CYP2A6* - **CYP2A6** is a minor **cytochrome P450 enzyme** that metabolizes a limited number of drugs and xenobiotics. - Its primary role is in the metabolism of **nicotine** and certain **tobacco-specific nitrosamines**, making it less globally significant for general drug detoxification compared to CYP3A4. *CYP2B6* - **CYP2B6** metabolizes a relatively small fraction of drugs, around **3% to 5%** of those currently in clinical use. - While it is important for the metabolism of some **antiretrovirals** and **antidepressants**, its contribution to overall drug metabolism and detoxification is considerably less extensive than that of CYP3A4.

Q: A young child weighing 20 kg is administered a drug at a dose of 100 mg/kg body weight. Given that the plasma concentration of the drug is 2 mg/dL and the clearance is 13,860 mL/hr, calculate the time required to reach steady state plasma concentration.

30 hours. ***30 hours*** - To reach **steady-state concentration**, approximately **5 half-lives (t½)** are required, at which point the drug reaches ~97% of steady state. - First, calculate the **volume of distribution (Vd)**: Total dose = 100 mg/kg × 20 kg = 2000 mg. Plasma concentration = 2 mg/dL = 20 mg/L. Therefore, **Vd = Dose/Cp = 2000 mg / 20 mg/L = 100 L**. - Next, calculate the **half-life (t½)** using the formula: **t½ = 0.693 × Vd / Cl**. Given **Clearance (Cl)** = 13,860 mL/hr = 13.86 L/hr, we get **t½ = (0.693 × 100 L) / 13.86 L/hr = 5 hours**. - Time to reach steady state = **5 × t½ = 5 × 5 hours = 25 hours**. While the calculated value is 25 hours, **30 hours (6 half-lives)** is the closest option and ensures steady state is definitively reached, as clinical practice often considers 4-6 half-lives as the range for steady state. *20 hours* - This duration represents only **4 half-lives**, which achieves approximately **94% of steady-state** concentration. - While close, this is slightly **premature** compared to the standard 5 half-lives required for steady state, and is further from the calculated 25 hours than the correct answer. *10 hours* - This duration represents only **2 half-lives**, which is **insufficient to reach steady-state** plasma concentration. - At 10 hours, the drug concentration would only be around **75% of steady-state**, not fully accumulated. *40 hours* - This duration represents **8 half-lives**, which is **excessively long** for achieving steady-state. - By this point, the drug would have been at **steady-state for several half-lives**, making this an unnecessarily prolonged estimate.

Question 1

Comparing cisplatin and carboplatin, which factor primarily accounts for the difference in nephrotoxicity between these two chemotherapeutic agents?

Accepted Answer

Different rates of renal clearance

Answer

Variability in DNA adduct formation

Answer

Difference in protein binding

Answer

Dose-dependent cellular uptake

Question 2

Which of the following statements is most accurate regarding why fentanyl is preferred over morphine for acute pain management in emergency settings?

Accepted Answer

Fentanyl is more suitable for acute pain management due to its rapid onset.

Answer

Morphine has a longer duration of action than fentanyl.

Answer

Fentanyl has lower lipid solubility than morphine.

Answer

Morphine is completely ineffective for acute pain management.

Question 3

In a drug exhibiting first-order kinetics, how would an increase in dose affect the time required to reach the steady-state concentration?

Accepted Answer

It would not change

Answer

It would decrease

Answer

It would increase

Answer

It would double

Question 4

The graph below shows dose-response curves for three drugs A, B, and C. Which of the following drugs has the highest potency?

Accepted Answer

Drug A

Answer

Drug B

Answer

Drug C

Answer

Both Drug A & B

Question 5

Which of the following statements is false regarding intracellular receptors?

Accepted Answer

They are the fastest acting receptors.

Answer

Act by regulating gene expression

Answer

Glucocorticoid receptors are a type of intracellular receptor.

Answer

DNA contains hormone responsive elements.

Question 6

What is the role of oxidation in biotransformation?

Accepted Answer

Functionalization reaction

Answer

Conjugation reaction

Answer

Synthetic reaction

Answer

Felson reaction

Question 7

Which of the following is the longest acting oral anticoagulant?

Accepted Answer

Bishydroxycoumarin

Answer

Warfarin

Answer

Acenocoumarol

Answer

Phenindione

Question 8

Glucuronidation takes place in?

Accepted Answer

Liver

Answer

RBC

Answer

Pancreas

Answer

Thyroid

Question 9

Most common enzyme for drug metabolism and detoxification reactions?

Accepted Answer

CYP3A4

Answer

CYP1A2

Answer

CYP2A6

Answer

CYP2B6

Question 10

A young child weighing 20 kg is administered a drug at a dose of 100 mg/kg body weight. Given that the plasma concentration of the drug is 2 mg/dL and the clearance is 13,860 mL/hr, calculate the time required to reach steady state plasma concentration.

Accepted Answer

30 hours

Answer

20 hours

Answer

10 hours

Answer

40 hours

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?